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Abstract
Purpose:  To  determine  whether  it  is  appropriate  to  routinely  undertake  surgery  if  ﬂat  epithelial
atypia (FEA)  or  pure  ﬂat  epithelial  atypia  (pFEA)  is  found  on  large-core  biopsy.
Patients  and  methods:  Between  2005  and  2010,  1678  large-core  biopsy  procedures  were  carried
out, which  led  to  136  FEA  sites  being  identiﬁed,  63  of  which  across  59  patients  were  pFEA  (four
patients had  two  sites  of  pFEA  each).  Forty-eight  patients  underwent  further  surgical  excision,
equating to  52  excised  sites  of  pFEA.
Results:  Of  the  52  operated  sites,  there  were  20  benign  lesions  (38%),  26  borderline  lesions
(56%), and  three  ductal  carcinomas  in  situ  (6%).  The  rate  of  histologic  underestimation  was  put
at 3.8%.  Of  the  three  cases  that  were  underestimated,  one  was  discarded  because  the  deﬁnitive
histology  was  not  representative  of  the  site  from  which  microcalciﬁcations  had  initially  been
taken. The  other  two  cases  that  were  underestimated  were  found  in  patients  with  an  increased
individual  risk  of  breast  cancer.
Conclusion:  In  patients  with  no  personal  or  ﬁrst-degree  family  history  of  breast  cancer,  after
complete or  subtotal  excision  under  radiology  of  the  radiological  lesion,  and  while  excluding
images ﬁtting  BI-RADS  5,  annual  monitoring  may  be  offered  as  an  alternative  to  surgical  excision
in view  of  the  absence  of  underestimation  found  in  our  study.
© 2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
In  2004,  breast  cancer  screening  in  France  was  rolled  out  to  women  aged  between  50
and  74,  and  this  was  combined  with  an  increase  in  mammography  monitoring  of  women
outside  this  age  range.  This  led  to  a  growing  number  of  abnormalities  being  identiﬁed,
including  microcalciﬁcations,  the  detection  of  which  was  improved  further  still  with  the
advent  of  digital  mammography.  From  this  resulted  an  increase  in  vacuum-assisted  biopsies
being  indicated,  as  well  as  new  pathological  entities  being  identiﬁed  such  as  ﬂat  epithelial
atypia  (FEA).
∗ Corresponding author.
E-mail address: l-ceugnart@o-lambret.fr (L. Ceugnart).
2211-5684/$ — see front matter © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
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According  to  the  2003  WHO  classiﬁcation,  ﬂat  epithelial
typia  (FEA)  is  an  ‘‘intraductal  alteration  characterized  by
eplacement  of  the  native  epithelial  cells  by  a  single  or  three
o  ﬁve  layers  of  mildly  atypical  cells.  The  ducts  involved  are
ariably  distended  and  often  contain  intraluminal  microcal-
iﬁcations  or  secretory  material’’  [1].
The  clinical  signiﬁcance  of  FEA  is  uncertain.
Some  authors  have  put  forward  the  theory  that  FEA  could
orrespond  to  a  premalignant  state  of  carcinoma  in  situ  or
nvasive  carcinoma,  particularly  tubular  carcinoma,  due  to
ytological,  immunohistochemical,  and  molecular  similari-
ies  [1—7].
Surgical  excision  is  therefore  usually  recommended
ecause  of  the  risk  of  underestimation,  which  ranges  in  the
iterature  from  0  to  25%  [8—13].
The  purpose  of  our  study  is  to  identify  our  own  rate  of
istologic  underestimation  and  to  compare  this  to  data  from
he  literature,  in  order  to  appreciate  how  appropriate  it  is
o  automatically  proceed  to  a  second  surgical  intervention.
atients and methods
his  study  was  carried  out  between  January  2005  and  July
010.  We  consecutively  included  48  female  patients  with  52
solated  FEA  lesions  identiﬁed  on  large-core  biopsy  speci-
ens,  who  then  proceeded  to  undergo  secondary  surgery.
atients
he  inclusion  criteria  were  the  identiﬁcation  of  pure  FEA
pFEA)  on  biopsy  specimens  and  subsequent  management
y  a  second  surgical  procedure.
The  exclusion  criteria  were  the  existence  of  lesions
ssociated  with  FEA  (atypical  ductal  hyperplasia,  lobular
eoplasia,  radial  scar,  phyllodes  tumour,  papilloma,  duc-
al  carcinoma  in  situ,  and  invasive  carcinoma)  or  a  second
urgical  procedure  not  taking  place.
Fibrocystic  breast  disease  and  ﬁbroadenomatoid  hyper-
lasia  were  not  considered  to  be  exclusion  criteria  because
f  their  benign  nature.
FEA  was  identiﬁed  on  136  of  the  1678  large-core  biopsy
pecimens  (8.1%)  that  were  taken  during  the  analysis  phase.
The  following  clinical  information  was  recorded  in  the
edical  ﬁles  in  order  to  describe  the  included  population:
ge,  personal  or  ﬁrst-degree  family  history  of  breast  cancer,
enopausal  status,  whether  using  hormone  replacement
herapy  for  menopausal  symptoms.
xamination technique
iagnostic  investigations
ll  of  the  radiology  investigations  (mammo-
rams  ±  sonograms)  that  had  been  used  as  the  basis  for
nding  large-core  biopsy  to  be  indicated  were  reassessed
y  a  team  of  two  radiologists,  one  senior  approved  to  carry
ut  the  second  reading  and  one  junior  who  deﬁned  the
esions  by:
type:  microcalciﬁcations/mass/microcalciﬁcations+mass/
architectural  distortion;
c
r
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maximum  diameter:  <  5  mm/5—10  mm/10—20  mm/  >
20  mm  (the  largest  of  the  two  measurements  taken  on
the  anteroposterior  and  lateral  views);
ACR  category  according  to  the  BI-RADS  classiﬁcation  [14].
A  comparison  with  mammogram  images  before  and  after
he  large-core  biopsy  procedure  allowed  us  to  estimate  what
ercentage  had  been  excised,  and  this  ﬁnding  was  grouped
nto  one  of  three  categories:  complete  (100%),  subtotal
90—99%),  or  partial  (<  90%).
arge-core  biopsy  sampling
he  52  vacuum-assisted  large-core  biopsies  were  carried  out
y  a  senior  radiologist  specialising  in  breast  pathology.
Forty-nine  were  carried  out  under  stereotactic  guid-
nce  (Mammotome  system:  Johnson  and  Johnson  Breast
are/Dedicated  table:  Mammotest  from  Siemens)  and  three
ere  ultrasound-guided  (nodule  seen  on  sonogram)  (Mam-
otome  Hand  Held,  Johnson  and  Johnson  Breast  Care).
The  needle  calibre  ranged  from  11  to  8  gauge  (G),
epending  on  breast  size.
For  each  procedure,  the  needle  calibre  used  and  the
otal  number  of  specimens  taken  were  recorded,  as  were
he  number  of  specimens  containing  microcalciﬁcations,
etermined  by  radiological  examination  of  the  biopsy
pecimens  carried  out  immediately  after  they  had  been
xcised.
When  the  excision  carried  out  under  radiology  was  com-
lete  or  subtotal,  a  metal  marker  clip  was  placed  in  situ  in
ase  a  second  surgical  intervention  needed  to  be  carried  out.
e  ensured  the  positioning  of  the  clip  was  correct  by  rou-
inely  carrying  out  post-procedure  imaging  after  eight  days
anteroposterior  and  lateral  views).
natomical  pathology
lmost  all  of  the  specimens  (52/52  or  100%  of  the
arge-core  biopsy  specimens  and  46/52  or  88%  of  the  par-
ial  mastectomy  specimens)  were  analysed  in  our  centre
y  three  anatomical  pathologists  experienced  in  breast
isease.
The  136  core  biopsy  specimens  that  contained  FEA  were
hosen  using  the  computerised  registers  of  the  anatomical
athology  laboratory  pathology  laboratory  of  our  center.
The  histology  reports  of  these  136  specimens  were
eassessed  by  an  anatomical  pathologist  specialised  in
reast  disease,  so  that  any  associated  lesion  (atypical  duc-
al  hyperplasia,  lobular  neoplasia,  radial  scar,  phyllodes
umour,  papilloma,  ductal  carcinoma  in  situ,  or  invasive  car-
inoma)  could  be  excluded.  This  led  to  63  sites  of  pure  FEA
eing  chosen.
The  same  anatomical  pathologist  reassessed  the  histology
eports  of  the  52  secondary  partial  mastectomy  specimens
n  order  to  identify  any  cases  of  underestimation.
Checks  were  made  to  ensure  that  each  excised  speci-
en  contained  a  metal  clip  and/or  post-biopsy  scar  tissue
hanges  to  conﬁrm  that  surgery  had  taken  place  in  the  cor-
ect  location.
The  lesions  found  in  the  partial  mastectomy  specimens
ere  classed  into  three  categories:
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• benign  lesions:  benign  proliferative  breast  disease,
ﬁbroadenomatoid  hyperplasia,  epithelial  hyperplasia
without  atypia,  or  columnar  cell  change;
• borderline  lesions:  atypical  ductal  hyperplasia  (ADH),  ﬂat
epithelial  atypia  (FEA),  lobular  neoplasia  in  situ  (LNIS),
radial  scar,  or  papilloma  [15].  If  several  borderline  lesions
appeared  together,  the  one  with  the  poorest  prognosis
was  counted.  LNIS  and  ADH  were  therefore  considered
over  FEA  when  counting  borderline  lesions;
• malignant  lesions:  carcinoma  in  situ  or  invasive  carci-
noma.
Only  malignant  lesions  were  taken  into  consideration
when  assessing  the  rate  of  histologic  underestimation.
Results
Of  the  1678  vacuum-assisted  core  biopsy  procedures  car-
ried  out  between  January  2005  and  July  2010,  136  sites  of
FEA  were  identiﬁed  (8.1%),  of  which  63  were  sites  of  pure
FEA  (3.8%  of  the  1678  large-core  biopsies)  and  these  were
seen  in  59  patients  (four  patients  had  two  sites  of  pure  FEA
each).  Seven  patients  (12%)  did  not  undergo  further  surgical
excision  because  the  multidisciplinary  team  suggested  that
monitoring  was  preferred  in  three  situations:
• the  atypia  was  extremely  focal  and  the  excision  under
radiology  was  complete  (four  patients);
(
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Table  1  Main  morphologic  features  of  the  large-core  biopsy  s
52  pure  ﬂat  epithelial  atypia  (FEA)  lesions.
52  pure  FEA  lesions
Imaging
Primary  lesion Site  of  isolated  mi
Mass  +  microcalciﬁ
Mass  only  
Architectural  disto
Hypoechoic  nodule
Maximum  diameter < 5  mm  
5—10  mm  
10—20  mm  
>  20  mm  
BI-RADS  classiﬁcation BI-RADS  3  
BI-RADS  4  
BI-RADS  5  
Large-core  biopsy  Stereotactic  
Guidance  modality  Ultrasound  
Needle  calibre 11  gauge  
8  gauge  
Mean  number  of  specimens  15  (5—45)
Mean  number  of  specimens
with  microcalciﬁcations
6 (0—17)  or  38%  of
Percentage  excised  under
radiology
100%  
90—99%  
<  90%  863
there  were  associated  abnormal  ﬁndings  that  justiﬁed
monitoring  by  mammogram  together  with  breast  MRI  (two
patients);
history  of  radiotherapy  in  the  ipsilateral  breast  (one
patient).
Four  patients  (7%)  were  lost  to  follow-up.
The  patients  who  did  not  undergo  surgery  were  excluded
rom  our  study  so  that  we  could  retain  a  homogenous  series
f  cases.
In  almost  90%  of  cases,  the  lesion  presented  in  the  form  of
 site  of  microcalciﬁcations,  which  were  smaller  than  1  cm
n  size  in  more  than  half  of  all  cases  (Table  1).
Forty-eight  patients  (81%)  underwent  immediate  further
urgery,  and  42  of  these  interventions  took  place  in  our  cen-
re.  Four  patients  presented  a  localisation  in  two  places,
hich  brought  the  total  number  of  lesions  included  to  52
ases.
Of  the  48  patients  included  in  our  study,  the  mean  age
as  51-years-old  (36—73  years  old);  11  patients  (23%)  had
 ﬁrst-degree  relative  with  a  history  of  breast  cancer,  and
ix  of  these  (12%)  had  developed  under  the  age  of  60;  six
12%)  had  a  personal  history  of  breast  cancer  (ipsilateral
r  contralateral)  and  two  (4%)  had  a  history  of  borderline
esions  of  atypical  ductal  hyperplasia;  in  total,  17  patients
35%)  had  a  personal  history  or  a  ﬁrst-degree  relative  with
 history  of  breast  cancer.  Twenty-ﬁve  patients  (52%)  were
ost-menopausal,  and  six  (12%)  of  these  were  taking  hor-
one  replacement  therapy.
pecimen  and  the  methods  used  to  take  specimens  for  the
crocalciﬁcations 45  (86%)
cations  2  (4%)
1  (2%)
rtion  +  microcalciﬁcations  1  (2%)
 3  (6%)
6  (12%)
21  (40%)
16  (31%)
9  (17%)
9  (17%)
37  (71%)
6  (12%)
49  (94%)
3  (6%)
34  (65%)
18  (35%)
 the  total  number  of  specimens
Complete  excision  19  (37%)
Subtotal  excision  19  (37%)
Partial  excision  14  (26%)
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The  main  morphologic  features  of  the  52  pure  FEA  lesions
re  summarised  in  Table  1,  together  with  information  about
he  large-core  biopsy  method.
Histologic  examination  of  the  surgical  biopsy  specimens
dentiﬁed  20  benign  lesions,  29  borderline  lesions,  and  three
alignant  lesions,  equating  to  a  histologic  underestimation
ate  of  5.8%  (Table  2).  The  most  commonly  identiﬁed  bor-
erline  lesion  was  pure  FEA  (13/29  or  45%  of  cases).  Scar
issue  from  the  large-core  biopsy  was  formally  identiﬁed  on
ll  except  one  of  the  surgical  biopsy  specimens  in  the  three
ases  of  underestimation  (case  2).
The  three  malignant  lesions  identiﬁed  were  ductal  carci-
omas  in  situ:  two  were  grade  2  and  one  was  grade  3.  There
as  no  proven  case  of  invasive  carcinoma.
The  ﬁrst  case  of  underestimation  (2007)  concerned  a
5-year-old  female  who  had  a  ﬁrst-degree  relative  with  a
istory  of  breast  cancer  before  the  age  of  60,  and  a  per-
onal  history  of  breast  cancer  in  2006  (ductal  carcinoma  in
itu)  that  had  been  treated  with  partial  mastectomy  and
adiotherapy.  During  her  annual  monitoring,  a  site  of  poly-
orphic  linear-clustered  microcalciﬁcations  (ACR  5)  with  a
aximum  size  of  between  10  and  20  mm  was  found,  and  this
arranted  a  vacuum-assisted  large-core  biopsy  (20  speci-
ens  taken,  ten  of  which  contained  microcalciﬁcations)  that
mounted  to  a  subtotal  excision  under  radiology.  In  view
f  her  personal  and  family  history  of  cancer,  and  the  ﬁnd-
ng  of  a  site  of  microcalciﬁcations  classed  as  ACR5  in  the
perated  breast  corresponding  to  FEA  together  with  a  site
f  ADH  being  diagnosed  in  the  contralateral  breast  at  the
ame  time,  the  patient  expressed  a  wish  to  undergo  a  pro-
hylactic  bilateral  mastectomy.  This  treatment  decision  was
pproved  in  the  multidisciplinary  meeting.  This  means  that
t  was  a  total  mastectomy  specimen  in  which  sites  of  grade
 DCIS  were  identiﬁed,  away  from  the  scar  tissue  of  the
arge-core  biopsy.  The  deﬁnitive  histologic  diagnosis  (grade
 DCIS)  did  not  formally  correlate  with  the  site  from  which
he  microcalciﬁcations  had  initially  been  taken.  This  case
annot  therefore  be  considered  to  be  an  underestimation  of
he  large-core  biopsy,  but  rather  an  associated  lesion  away
rom  the  site.
The  second  case  of  underestimation  (2007)  concerned
 48-year-old  female  who  presented  an  ipsilateral  syn-
hronous  breast  cancer  (tubulolobular  adenocarcinoma).
he  initial  assessment  of  this  subclinical  image  showed,
round  3  cm  away  from  the  opacity  that  corresponded  to
F
p
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Table  2  Histology  of  the  excision  specimens  of  the  52  pure  ﬂa
specimens.
Deﬁnitive  histology
Benign  lesions  
Number  of  lesions
(n  =  52)
20  (38%)
FEA: ﬂat epithelial atypia; LNIS: lobular neoplasia in situ; ADH: atypicaL.  Ceugnart  et  al.
he  tubulolobular  adenocarcinoma,  a site  of  microcalciﬁca-
ions  classed  as  ACR3,  with  a  maximum  diameter  of  less  than
 mm,  and  this  warranted  a  vacuum-assisted  core  biopsy
18  specimens  taken,  of  which  six  contained  microcalciﬁ-
ations),  amounting  to  complete  excision  under  radiology.
fter  the  multidisciplinary  meeting,  it  was  decided  that  a
ouble  tumourectomy  was  indicated,  the  ﬁrst  to  remove
he  subclinical  ACR6  mass  (conﬁrming  the  histologic  diag-
osis  of  tubulolobular  adenocarcinoma),  and  the  second  to
emove  the  site  from  which  the  core  biopsy  specimens  had
een  taken.  On  excision  of  this  second  area,  FEA  lesions  sur-
ounding  sites  of  grade  2  DCIS  only  millimetres  in  size  were
dentiﬁed.  However,  the  usual  ﬁnding  of  large-core  biopsy
car  tissue  was  not  seen,  probably  because  of  signiﬁcant
lectrocoagulation  hindering  interpretation.  In  spite  of  this,
ltrasound-guided  preoperative  identiﬁcation  of  both  sites
sing  methylene  blue  (the  ACR6  mass  on  the  one  hand,  and
he  metal  marker  clip  on  the  other)  ensured  that  the  surgery
as  guided  towards  the  correct  location.
The  third  case  of  underestimation  (2006)  concerned  a
8-year-old  female  who  had  a  ﬁrst-degree  relative  with  a
istory  of  breast  cancer  developed  before  the  age  of  60.  The
nding  of  a  site  of  polymorphic  microcalciﬁcations  classed
s  ACR5,  with  a  maximum  diameter  of  35  mm,  warranted
 vacuum-assisted  large-core  biopsy  (13  specimens  taken,
even  of  which  contained  microcalciﬁcations),  and  the  size
f  this  site  meant  that  only  a  partial  excision  under  radi-
logy  was  possible.  Anatomical  pathology  examination  of
he  excision  specimen  from  the  secondary  partial  mastec-
omy  identiﬁed  a  site  of  grade  2  DCIS.  The  main  clinical  and
orphologic  features,  information  about  the  biopsy  method,
nd  the  deﬁnitive  histology  of  these  three  cases  of  underes-
imation  are  summarised  in  Table  3.
If  we  exclude  the  case  in  which  the  histology  of  the
urgically  excised  specimen  did  not  correlate  to  the  his-
ology  of  the  large-core  biopsy  specimen  (case  1),  the
istologic  underestimation  rate  of  pure  FEA  lesions  diag-
osed  by  vacuum-assisted  large-core  biopsy  is  3.8%  (2/52).
iscussionlat  epithelial  atypia  (FEA)  is  an  entity  deﬁned  by  anatomical
athology  that  was  described  in  2003  in  the  WHO  clas-
iﬁcation  of  breast  disease.  It  forms  part  of  the  disease
t  epithelial  atypia  lesions  diagnosed  on  large-core  biopsy
Borderline  lesions  Malignant  lesions
29 (56%)  3  (6%)
FEA:  13  DCIS:  3
ADH:  4 Invasive  carcinoma:  0
LNIS:  7
Radial  scar:  3
Mixed  lesions:  2
l ductal hyperplasia; DCIS: ductal carcinoma in situ.
Pure  ﬂat  epithelial  atypia:  Is  there  a  place  for  routine  surgery?  865
Table  3  Main  clinical  and  morphologic  features,  method  of  taking  the  large-core  biopsy,  and  deﬁnitive  histology  in  the
three  cases  of  underestimation.
Case  No.  1  Case  No.  2  Case  No.  3
Clinical
Age  55-years-old  48-years-old  48-years-old
Family  history  Yes  <  60-years-old  No  Yes  <  60-years-old
Personal  history DCIS Invasive  carcinoma No
Ipsilateral Ipsilateral
Synchronous
Imaging
Primary  lesion Site  of  microcalciﬁcations
Maximum  diameter  10—20  mm  <  5  mm  >  20  mm
BI-RADS  BI-RADS  5  BI-RADS  3  BI-RADS  5
Large-core  biopsy
Needle  calibre 11  G 11 G  8  G
Number  of  specimens 20  18  13
Number  of  specimens  with  microcalciﬁcations 10  6  7
Radiological  excision Subtotal  Complete  Partial
Histology
Deﬁnitive  histology  DCIS  grade  3  DCIS  grade  2  DCIS  grade  2
b
i
(
t
o
i
p
i
n
h
o
[
n
s
a
h
s
l
c
p
p
b
w
e
e
p
o
t
wBiopsy  representative  of  surgical  excision?  No  
spectrum  of  ‘‘columnar  cell  lesions’’,  a  group  to  which  var-
ious  different  terminologies  have  been  applied  since  the
1940s.  For  Jara-Lazaro  et  al.  [16],  some  of  these  terms  sug-
gest  a  benign  process,  such  as  ‘‘blunt  duct  adenosis’’  [17],
‘‘pretubular  hyperplasia’’  [18],  ‘‘columnar  alteration  of  lob-
ules’’  [19],  ‘‘columnar  alteration  with  prominent  apical
snouts  and  secretions  (CAPSS)’’  [20],  and  ‘‘enlarged  lobular
units  with  columnar  alteration’’  (ELUCA)  [21].  By  contrast,
other  terms  are  suggestive  of  malignancy,  including  ‘‘ductal
intraepithelial  neoplasia  1  —  ﬂat  type’’  [9],  ‘‘clinging  car-
cinoma  —  monomorphic  type’’  [22]  and  ‘‘clinging  in  situ
duct  carcinoma  —  ﬂat  type’’  [23].  The  variability  of
terms  used  illustrates  the  polymorphic  nature  of  FEA
lesions.
FEA  is  characterised  by  the  presence  of  cellular  changes
and  it  differs  from  ADH  and  DCIS  due  to  an  absence  of
architectural  atypia  [1].  Some  authors  have  put  forward  the
theory  that  FEA  could  be  a  premalignant  state  of  carcinoma
in  situ  or  invasive  carcinoma,  especially  invasive  tubular  car-
cinoma,  because  of  cytological,  immunohistochemical,  and
molecular  similarities  [1—7].  However,  there  is  no  consen-
sus  and  one  recent  work  has  just  shown  in  a  population  of
77  patients  with  cancer  who  had  been  diagnosed  with  FEA
on  a  previous  biopsy  that  the  features  of  these  neoplasms
were  similar  to  those  seen  in  sporadic  cases  [24].  The  risk  of
cancer  during  long-term  monitoring  was  estimated  by  Bou-
los  et  al.  [25]  to  be  1.47%  for  cases  of  FEA  compared  to  a
rate  of  3.5%  in  ADH.  There  is  no  current  consensus  on  how
to  manage  FEA,  probably  due  to  the  range  of  synonyms  that
existed  before  the  WHO  established  a  collective  term,  and
because  there  is  minimal  published  data.  It  is  for  this  reason
that  the  treatment  algorithm  deﬁned  for  ADH  (which  advises
routine  secondary  surgical  excision  [2—29])  has  been  applied
to  cases  of  FEA  in  our  centre.  The  purpose  of  this  study  is  to
assess  whether  this  procedure  is  appropriate.
r
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(Yes  Yes
Pure  FEA  lesions  were  identiﬁed  on  3.8%  of  the  large-core
iopsies  carried  out  over  the  6  years  of  the  study.  This  rate
s  relatively  close  to  that  identiﬁed  by  some  other  authors
3.6%  for  Martel  [9],  3.7%  for  Piubello  [11]),  but  it  exceeds
he  1.5%  described  in  the  multicentre  French  study  carried
ut  by  Lavoué  et  al.  [12]. In  the  latter  study,  this  difference
s  attributed  to  the  extremely  strict  criteria  used  to  diagnose
ure  FEA.  By  contrast,  our  ﬁgure  is  below  the  4.9%  found
n  the  Saint-Cloud  team’s  study,  which  covered  the  largest
umber  of  cases.
There  is  a  high  rate  of  further  surgery  in  our  study  (81%),
igher  than  that  seen  in  most  of  the  other  studies  previ-
usly  published  (32%  for  Noel  et  al.  [4],  68%  for  David  et  al.
30], 70%  for  Noske  et  al.  [10]) and  similar  to  that  of  Ingeg-
oli  et  al.’s  study  [13]  (83%)  which  did,  however,  cover  a
maller  number  of  pFEA  sites  (18,  15  of  which  were  oper-
ted).  Lavoué  et  al.’s  study  [12]  included  only  patients  who
ad  undergone  surgery  (60  cases).  This  high  rate  of  further
urgery  is  an  indicator  of  the  quality  of  our  study,  with  a
ow  rate  of  patients  lost  to  follow-up  (7%)  and  very  good
ompliance  on  the  part  of  both  patients  and  surgeons  to  the
redeﬁned  protocol.
In  our  study,  the  rate  of  histologic  underestimation  of
ure  FEA  lesions  diagnosed  by  vacuum-assisted  large-core
iopsy  was  put  at  3.8%  (2/52).  This  underestimation  rate
as  relatively  low  compared  to  the  data  from  the  lit-
rature,  where  it  ranges  from  0%  to  25%  [4,8—13],  and
ven  more  so  since  our  study  concerned  a  population  of
atients  attending  a  cancer  specialist  centre.  Indeed,  31%
f  the  patients  included  in  our  study  had  a  personal  his-
ory  or  ﬁrst-degree  relative  with  a  history  of  breast  cancer,
hich  is  not  representative  of  the  general  population.  In  a
ecently  published  meta-analysis  [31],  the  rate  of  underesti-
ation  for  ﬂat  epithelial  atypia  lesions  was  calculated  at  17%
10—27%  with  a  conﬁdence  interval  of  95%)  for  389  cases  that
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nderwent  surgery  in  668  biopsied  patients.  However,  in  this
tudy,  the  majority  of  the  percutaneously  obtained  speci-
ens  had  been  taken  by  standard  core-needle  biopsy,  and
n  the  majority  of  cases  the  lesions  that  they  were  associated
ith  were  described  (lobular  neoplasia  and/or  atypical  duc-
al  hyperplasia).  A  summary  of  the  rates  of  underestimation
s  brought  together  in  Table  4.
Our  two  cases  of  underestimation  arose  in  patients  with
 raised  personal  risk  of  breast  cancer:  one  with  an  ipsi-
ateral  synchronous  cancer  and  the  other  with  a  history  of
 ﬁrst-degree  relative  with  breast  cancer  before  the  age
f  60.  There  was  no  case  of  underestimation  found  in  any
atient  who  did  not  have  this  kind  of  history.  The  existence
f  a  personal  history  or  a  ﬁrst-degree  relative  with  a  his-
ory  of  breast  cancer  could  therefore  constitute  a  risk  factor
or  histologic  underestimation  of  FEA  lesions  diagnosed  on
arge-core  biopsy.  This  clinical  criterion  was  not  identiﬁed
s  a  signiﬁcant  risk  factor  by  David  et  al.  [30].
With  regard  to  the  method  for  taking  the  large-core
iopsy  specimen,  the  calibre  of  the  needle  used  and  the
ercentage  excised  under  radiology  do  not  allow  us  to  make
 judgement  about  histologic  underestimation.  In  both  our
xperience  and  in  the  literature,  there  was  no  signiﬁcant
ifference  in  the  rate  of  underestimation  whether  an  11  G
r  8  G  needle  was  used  for  a  large-core  biopsy  [30]. How-
ver,  underestimation  is  higher  when  core-needle  biopsies
re  used  (14  G—18  G  needles)  as  illustrated  by  the  Kunju
tudy  [8],  which  covered  only  pure  FEA,  and  this  conclusion
as  borne  out  by  the  recent  meta-analysis  into  FEA  in  which
here  was  17%  underestimation  with  core-needle  biopsies  as
gainst  12%  with  large-core  biopsies  [31].
The  features  deﬁning  a  site  of  microcalciﬁcations  accord-
ng  to  the  BI-RADS  classiﬁcation  do  not  seem  to  add  any
urther  distinction  in  terms  of  histologic  underestimation,
onﬁrming  recent  data  on  the  lack  of  speciﬁcity  in  mam-
ogram  images  [32].  The  most  commonly  seen  feature  is
t
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Table  4  Rate  of  underestimation  of  ﬂat  epithelial  atypia  (FEA
studies.
Biopsy  Surgical  excision
Pure  FEA
operated
Absent  or
benign  lesion
(%)
David  et  al.,  2006  [30]  n  =  40  9  (22.5)  
Kunju  and  Kleer,  2007  [8]  n  =  12  3  (25)  
Noske  et  al.,  2010  [10]  n  =  30  11  (36.6)  
Piubello  et  al.,  2009  [11]  n  =  20  4  (20)  
Noël  et  al.,  2006  [4]  n  =  20  4  (20)  
Ingegnoli  et  al.,  2010  [13]  n  =  15  12  (80)  
Lavoué  et  al.,  2011  [12]  n  =  60  26  (43)  
Peres  et  al.  2012  [33]  n  =  95  NR  
Our  study,  2012 n  =  52  20  (38)
FEA: ﬂat epithelial atypia; LNIS: lobular neoplasia in situ; ADH: atypica
ductal carcinoma.L.  Ceugnart  et  al.
icrocalciﬁcations  (60%)  that  are  amorphous  (65%)  and  very
ften  in  clusters  (70%).  Masses  are  found  more  rarely,  and
hey  are  often  irregular  in  shape  with  microlobulation  [32].
he  BI-RADS  classiﬁcation  also  demonstrated  poor  speciﬁcity
n  our  study  since  four  sites  of  microcalciﬁcation  classed
s  BI-RADS  5,  one  of  which  had  a  maximum  diameter  of
ver  20  mm,  turned  out  to  be  histologically-proven  pure
EA  lesions.  Equally,  one  of  the  cases  of  underestimation
as  identiﬁed  for  a  site  classiﬁed  as  BI-RADS  3  that  was
ound  in  a  specimen  taken  in  the  assessment  of  an  ipsilat-
ral  synchronous  cancer.  Clearly,  the  average  reproducibility
f  the  BI-RADS  classiﬁcation,  especially  for  microcalciﬁca-
ions,  could  be  one  explanatory  factor.  However,  David  et  al.
30]  suggested  that  the  size  of  the  site  of  calciﬁcations
>  20  mm)  could  be  a risk  factor  for  histologic  underesti-
ation,  especially  when  it  was  impossible  to  achieve  full
xcision  of  the  lesion.  This  criterion  is  found  in  the  Peres
t  al.  study  [33]  since  the  rate  of  underestimation  is  twice
s  high  in  cases  of  incomplete  excision  under  radiology  (21
ersus  10%),  although  it  does  not  reach  a  threshold  of  sig-
iﬁcance.  On  the  contrary,  this  criterion  is  not  held  to  be
tatistically  signiﬁcant  by  David  et  al.  [30].
In  our  study,  the  extent  of  excision  under  radiology  (com-
lete,  subtotal,  or  partial)  does  not  seem  to  be  a  criterion
or  drawing  any  distinctions,  since  out  of  the  14  cases  of
artial  excision  under  radiology  (<  90%),  only  a  single  case
f  underestimation  was  found  (case  3).  Nor  did  complete
xcision  under  radiology  mean  there  was  no  risk  of  under-
stimation,  as  one  of  our  case  studies  shows  (case  2).  The
ubjective  nature  of  making  an  assessment  of  the  degree
f  excision  when  it  is  incomplete  makes  it  difﬁcult  to  draw
 comparison  between  different  studies.  In  the  same  way,
he  way  in  which  this  parameter  is  assessed  can  give  rise
o  discrepancies  (assessment  made  on  imaging  to  establish
he  target  or  on  repeat  imaging  with  or  without  enlarge-
ents).  Both  anteroposterior  and  lateral  images  that  are
)  diagnosed  by  vacuum-assisted  large-core  biopsy  in  recent
FEA
(%)
ADH
(%)
LNIS
(%)
DCIS or  IDC
(%)
19  (47.5)  5  (12.5)  7  (17.5)
5  (42)  1  (8)  3  (25)
15  (50)  1  (3.4)  1  (3.4)  2  (6.6)
10  (50)  1  (5)  5  (25)  0  (0)
8  (40)  4  (20)  4  (20)  0  (0)
3  (20)
14  (23)
10  (10.5)
13  (25)  4  (8)  7  (13)  2  (3.8)
Others:  5  (10)  +  1
non-signiﬁcant
case
l ductal hyperplasia; DCIS: ductal carcinoma in situ; IDC: invasive
ry?  
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sPure  ﬂat  epithelial  atypia:  Is  there  a  place  for  routine  surge
strictly  post-biopsy  need  to  be  compared  routinely  with  the
pre-biopsy  imaging  in  order  to  assess  whether  the  excision
is  complete  or  not  as  well  as  clip  positioning.  The  extent
of  excision  under  radiology  (complete,  subtotal  or  partial)
remains  one  of  the  major  criteria  for  validating  the  quality
of  the  technique  of  a  large-core  biopsy  procedure  and  for
assessing  the  correlation  between  radiology  and  histology.
It  is  therefore  essential  to  propose  further  surgery  where
there  is  partial  excision,  especially  if  the  image  is  classed
as  BI-RADS  5.  In  our  study,  in  two  out  of  the  three  cases  of
underestimation  there  were  microcalciﬁcations  classiﬁed  as
BI-RADS  5.
The  study  that  found  the  closest  rate  of  histologic  under-
estimation  to  ours  was  that  of  Noske  et  al.  (6.6%)  [10], but
this  study  covered  a  lower  number  of  sites  of  pure  FEA  (30
sites).  Neither  Piubello  et  al.  [11]  nor  Noel  et  al.  [4]  found
any  cases  of  carcinoma  in  situ  and/or  invasive  carcinoma
after  immediate  further  surgical  excision  of  residual  micro-
calciﬁcations  in  a  relatively  small  series  of  20  sites  of  pure
FEA.
By  contrast,  Ingegnoli  et  al.  [13],  Lavoué  et  al.  [12]  and
Peres  et  al.  [33]  recently  reafﬁrmed  the  need  for  further
surgical  excision  due  to  high  rates  of  histologic  underesti-
mation  of  20%,  13%,  and  10%  respectively.  It  is  interesting
to  compare  our  work  with  the  last  two  studies  because
they  took  place  in  other  institutions  of  the  CFLCC  net-
work  of  specialist  cancer  centres  in  France.  Lavoué  carried
out  a  multicentre  study  involving  ﬁve  centres  and  includ-
ing  60  sites  of  pure  FEA:  all  specimens  taken  by  large-core
biopsy  were  re-evaluated  retrospectively  by  two  anatomical
pathologists  who  were  unaware  of  the  deﬁnitive  histologic
diagnosis.  Peres  et  al.  [33]  brought  together  all  cases  of  FEA,
whether  associated  with  lesions  or  otherwise  (230  cases),
for  a  centralised  assessment  by  experienced  pathologists
at  the  Saint-Cloud  CFLCC  centre.  The  population  included
in  these  studies  was  comparable  to  ours  in  terms  of  age
and  menopausal  status.  However,  a  higher  proportion  of
our  patients  presented  a  family  history  (23%  vs.  18%  for
Lavoué  and  14%  for  Peres)  or  personal  history  (12%  com-
pared  to  3%  for  Lavoué)  of  breast  cancer.  The  very  different
rates  of  underestimation  (3.8%,  13%,  and  10%  respectively)
could  in  part  be  explained  by  the  average  reproducibility
of  anatomical  pathology  criteria  in  spite  of  the  assessment
being  made  by  pathologists  who  were  specialised  in  breast
disease.  Additionally,  depending  on  their  respective  expe-
rience  and  possibly  on  local  consensus,  some  teams  must
prefer  to  point  to  a  diagnosis  of  ductal  carcinoma  in  situ
when  the  large-core  biopsy  specimen  produces  ambiguous
results,  while  other  teams  will  put  forward  a  diagnosis  of
FEA,  and  this  inevitably  leads  to  different  rates  of  underes-
timation.
In  view  of  our  results,  with  the  low  rate  of  histologic
underestimation  identiﬁed  and  cases  of  underestimation
being  highlighted  only  in  patients  with  an  increased  individ-
ual  risk  of  breast  cancer,  we  suggest  abstaining  from  surgery
when  patients  are  diagnosed  with  pure  FEA  based  on  large-
core  biopsy  if  the  following  criteria  are  met:  no  personal
history  (current  or  previous)  or  ﬁrst-degree  relative  with  a
history  of  breast  cancer,  imaging  classed  as  BI-RADS  3  or  4,
and  complete  or  subtotal  excision  under  radiology  of  the
radiological  lesion.  This  deﬁnition  avoids  the  subjectivity
inherent  to  the  process  of  estimating  the  percentage  of  the
t
t
u
n867
esion  excised  under  radiology.  This  proposal  is  almost  iden-
ical  to  that  made  very  recently  by  De  Mascarel  et  al.  based
n  a  large-scale  series  conducted  at  a  large  specialist  cancer
entre  in  Bordeaux  [34].
The  underestimation  rates  of  pFEA  reported  in  the  liter-
ture  are  restated  in  Table  4.
As  discussed  by  Kunju  et  al.  [8],  the  solution  may
ie  in  the  discovery  of  biomarkers  that  are  able  to  pre-
ict  which  sites  of  FEA  are  likely  to  be  associated  with
 carcinoma,  as  this  would  guide  the  management  of
atients  either  towards  further  surgical  excision  or  close
onitoring.
In  addition,  if  there  were  clinical  and/or  radiological
riteria  that  were  associated  with  a  signiﬁcantly  increased
isk  of  histologic  underestimation,  then  these  could  be  use-
ul  tools  for  making  treatment  decisions.
The  main  source  of  bias  in  our  study  could  arise  from  not
utomatically  undertaking  a  second  reading  of  the  large-
ore  biopsy  specimen  or  the  partial  mastectomy  specimen
lides,  or  from  not  having  a  ‘‘blind’’  second  reading  of
he  slides  as  Lavoué  et  al.  did  [12]. Yet  diagnosing  and
dentifying  FEA  constitutes  a  challenge  for  the  anatomical
athologist  and  there  is  signiﬁcant  inter-  and  intra-observer
ariability  [35,36].  Almost  all  of  our  specimens  (52/52  or
00%  of  the  large-core  biopsy  specimens  and  46/52  or  88%
f  the  partial  mastectomy  specimens)  were  analysed  in  our
entre  by  three  anatomical  pathologists  who  are  experi-
nced  in  breast  disease.  In  view  of  the  very  low  rate  of
nderestimation  in  our  study,  we  can  conclude  that  there
s  relatively  high  reproducibility  in  the  histologic  diagnoses
ade  by  our  team.
It  should  be  noted  that  distinguishing  the  borderline
esions  associated  with  FEA  (Table  4)  had  only  a  minimal
mpact  on  the  subsequent  management  of  these  patients,
ecause  the  fact  of  their  being  identiﬁed  led  to  annual  moni-
oring  either  being  initiated  or  continued,  irrespective  of  the
xact  nature  of  the  lesion.  This  parameter  could  be  taken
nto  consideration  in  the  future  if  work  was  carried  out  that
mended  the  frames  of  reference,  in  particular  the  indica-
ions  for  further  surgery  after  large-core  biopsy.  Indeed,  a
ecent  study  [25]  showed  that  discovering  an  FEA  only  very
lightly  increased  the  risk  of  developing  breast  cancer  at  a
ater  date.  Furthermore,  the  few  neoplasms  that  are  dis-
overed  later  are  luminal  A  type,  which  means  they  are
ow-grade  in  terms  of  progression.  Based  on  these  kind  of
rguments,  we  could  move  away  from  the  established  annual
onitoring  and  propose  follow-up  every  2  years  while  incor-
orating  patients  in  the  relevant  age  range  back  into  the
rganised  screening  system.
The  other  weak  points  in  our  study  consist  of  the  absence
f  further  surgical  excision  in  11  patients  (in  seven  of  these
atients,  annual  monitoring  was  indicated,  while  the  other
our  were  lost  to  follow-up)  and  a  failure  to  identify  the
arge-core  biopsy  scar  tissue  on  the  partial  mastectomy
pecimen  in  one  of  our  two  cases  of  proven  underestima-
ion.  However,  the  biopsy  scar  tissue  was  identiﬁed  on  all
f  the  other  partial  mastectomy  specimens,  and  this  con-
titutes  a  major  quality  criterion  in  terms  of  proving  that
he  post-biopsy  surgical  excision  was  adequate.  This  means
hat  we  did  not  have  to  include  routine  long-term  follow-
p  in  our  study  in  order  to  screen  for  possible  surgical  false
egatives.
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onclusion
n  our  study,  the  rate  of  histologic  underestimation  of  pure
EA  lesions  identiﬁed  on  vacuum-assisted  large-core  biop-
ies  is  estimated  at  3.8%  after  further  surgical  excision.  Our
wo  cases  of  underestimation  were  found  in  patients  with  an
ncreased  personal  risk  of  breast  cancer.  These  observations
ead  us  to  propose  initiating  monitoring  as  an  alternative  to
urther  surgical  excision  in  patients  who  have  no  personal
r  ﬁrst-degree  family  history  of  breast  cancer  when  there
as  been  complete  or  subtotal  excision  under  radiology  of
he  site  of  microcalciﬁcations,  except  for  when  images  are
lassed  as  BI-RADS  5.
The  intervals  between  monitoring  would  remain  yearly
lthough  some  recent  studies  seem  to  show  that  the  risk
f  developing  cancer  is  low,  often  occurring  much  later,
ith  slow-growing  disease.  Further  studies  will  be  needed
o  validate  this  proposed  management  approach  and  also  to
ecide  on  how  often  monitoring  should  take  place.  Person-
lising  monitoring  in  terms  of  individual,  family,  radiological
nd  histologic  factors  while  genomics  progresses  will  be
ne  of  the  challenges  in  the  years  to  come.  The  differ-
nces  in  underestimation  rates  reported  in  the  literature
emonstrate  how  important  it  is  for  each  centre  to  ana-
yse  its  own  databases  and  to  work  in  multidisciplinary
eams.
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